These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 32531723)
1. Genetic progression of post-transplant Burkitt-like lymphoma case with 11q-Gain/Loss and MYC amplification. Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Malawska N; Blachnio K; Bystydzienski Z; Borysiuk A; Nowakowska B; Pienkowska-Grela B Cancer Genet; 2020 Jul; 245():1-5. PubMed ID: 32531723 [TBL] [Abstract][Full Text] [Related]
2. The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS. Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Borkowska K; Kotyl A; Blachnio K; Bystydzienski Z; Nowakowska B; Pienkowska-Grela B Am J Clin Pathol; 2017 Dec; 149(1):17-28. PubMed ID: 29272887 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration. Rymkiewicz G; Grygalewicz B; Chechlinska M; Blachnio K; Bystydzienski Z; Romejko-Jarosinska J; Woroniecka R; Zajdel M; Domanska-Czyz K; Martin-Garcia D; Nadeu F; Swoboda P; Rygier J; Pienkowska-Grela B; Siwicki JK; Prochorec-Sobieszek M; Salaverria I; Siebert R; Walewski J Mod Pathol; 2018 May; 31(5):732-743. PubMed ID: 29327714 [TBL] [Abstract][Full Text] [Related]
4. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752 [TBL] [Abstract][Full Text] [Related]
5. A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell Lymphomas. Horn H; Kalmbach S; Wagener R; Staiger AM; Hüttl K; Mottok A; Bens S; Traverse-Glehen A; Fontaine J; Siebert R; Rosenwald A; Ott G Am J Surg Pathol; 2021 Mar; 45(3):356-364. PubMed ID: 33136583 [TBL] [Abstract][Full Text] [Related]
6. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. Au-Yeung RKH; Arias Padilla L; Zimmermann M; Oschlies I; Siebert R; Woessmann W; Burkhardt B; Klapper W Br J Haematol; 2020 Sep; 190(5):753-763. PubMed ID: 32239695 [TBL] [Abstract][Full Text] [Related]
7. [Clinicopathologic characteristics of Burkitt-like lymphoma with chromosome 11q aberration]. Wei P; Zhang YL; Xie JL; Zheng YY; Liu W; Zhou XG Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):176-179. PubMed ID: 29534356 [No Abstract] [Full Text] [Related]
8. High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases. Shestakova A; Shao L; Smith LB; Ryan R; Bedell V; Murata-Collins J; Zhang W; Perry AM; Song JY Hum Pathol; 2023 Jun; 136():34-43. PubMed ID: 36997031 [TBL] [Abstract][Full Text] [Related]
9. Application of 2016 WHO classification in the diagnosis of paediatric high-grade Zhang L; Brown LE; Bowen LM; McCarthy LC; Cooley LD; Repnikova E; Gener MA; Garola R; August KJ; Hays JA; Zwick DL; Li W J Clin Pathol; 2020 Sep; 73(9):563-570. PubMed ID: 31964683 [TBL] [Abstract][Full Text] [Related]
10. Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. Gonzalez-Farre B; Ramis-Zaldivar JE; Salmeron-Villalobos J; Balagué O; Celis V; Verdu-Amoros J; Nadeu F; Sábado C; Ferrández A; Garrido M; García-Bragado F; de la Maya MD; Vagace JM; Panizo CM; Astigarraga I; Andrés M; Jaffe ES; Campo E; Salaverria I Haematologica; 2019 Sep; 104(9):1822-1829. PubMed ID: 30733272 [TBL] [Abstract][Full Text] [Related]
11. Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern. Ferreiro JF; Morscio J; Dierickx D; Marcelis L; Verhoef G; Vandenberghe P; Tousseyn T; Wlodarska I Haematologica; 2015 Jul; 100(7):e275-9. PubMed ID: 25795716 [No Abstract] [Full Text] [Related]
12. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma. Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902 [TBL] [Abstract][Full Text] [Related]
13. [Clinicopathological and molecular genetic features of Burkitt-like lymphoma with 11q aberration]. Zhang YP; Zhang L; Zhang DD; Wang GN; Zhao WG; Jian XY; Li WC Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):604-608. PubMed ID: 34078047 [No Abstract] [Full Text] [Related]
18. Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation's 2017 classification. Szumera-Ciećkiewicz A; Rymkiewicz G; Grygalewicz B; Jesionek-Kupnicka D; Gruchała A; Ziarkiewicz-Wróblewska B; Gałązka K; Reszeć J; Borg K; Prochorec-Sobieszek M Pol J Pathol; 2018; 69(1):1-19. PubMed ID: 29895122 [TBL] [Abstract][Full Text] [Related]
19. Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature. Woroniecka R; Rymkiewicz G; Szafron LM; Blachnio K; Szafron LA; Bystydzienski Z; Pienkowska-Grela B; Borkowska K; Rygier J; Kotyl A; Malawska N; Wojtkowska K; Parada J; Borysiuk A; Murcia Pienkowski V; Rydzanicz M; Grygalewicz B PLoS One; 2022; 17(2):e0263980. PubMed ID: 35167621 [TBL] [Abstract][Full Text] [Related]
20. Burkitt-like lymphoma with 11q aberration. Collins K; Mnayer L; Shen P Clin Case Rep; 2019 Sep; 7(9):1823-1824. PubMed ID: 31534767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]